Search

Rodney Barnett White

Examiner (ID: 4089, Phone: (571)272-6863 , Office: P/3636 )

Most Active Art Unit
3636
Art Unit(s)
3636, 3507, 3624
Total Applications
3742
Issued Applications
3058
Pending Applications
192
Abandoned Applications
490

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17685899 [patent_doc_number] => 20220193191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA [patent_app_type] => utility [patent_app_number] => 17/599034 [patent_app_country] => US [patent_app_date] => 2020-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599034 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/599034
LIPOCALIN MUTEIN FOR TREATMENT OF ASTHMA Mar 24, 2020 Abandoned
Array ( [id] => 17593574 [patent_doc_number] => 20220143147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS [patent_app_type] => utility [patent_app_number] => 17/440445 [patent_app_country] => US [patent_app_date] => 2020-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440445 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440445
INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS Mar 17, 2020 Pending
Array ( [id] => 17655408 [patent_doc_number] => 20220175873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => SYNTHETIC NEUROMODULATORY PEPTIDES [patent_app_type] => utility [patent_app_number] => 17/437331 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -96 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437331 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/437331
SYNTHETIC NEUROMODULATORY PEPTIDES Mar 12, 2020 Pending
Array ( [id] => 16108615 [patent_doc_number] => 20200206330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-02 [patent_title] => PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE [patent_app_type] => utility [patent_app_number] => 16/815068 [patent_app_country] => US [patent_app_date] => 2020-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815068 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/815068
PARTNER OF SLD FIVE 1 (PSF1)-DERIVED PEPTIDE Mar 10, 2020 Abandoned
Array ( [id] => 17671106 [patent_doc_number] => 20220184273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => PARTICULATE GEL FOR THE TREATMENT OF A BLEEDING IN THE SINUS OR NASAL CAVITY [patent_app_type] => utility [patent_app_number] => 17/436759 [patent_app_country] => US [patent_app_date] => 2020-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5900 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436759 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436759
PARTICULATE GEL FOR THE TREATMENT OF A BLEEDING IN THE SINUS OR NASAL CAVITY Mar 7, 2020 Pending
Array ( [id] => 17654496 [patent_doc_number] => 20220174961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => FUNCTIONAL PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AGAINST PHYTOPATHOGENIC MICROORGANISMS [patent_app_type] => utility [patent_app_number] => 17/436853 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9660 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436853 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436853
FUNCTIONAL PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AGAINST PHYTOPATHOGENIC MICROORGANISMS Mar 5, 2020 Pending
Array ( [id] => 17625805 [patent_doc_number] => 20220160820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => MODULATORS OF COMPLEMENT ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/437082 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/437082
MODULATORS OF COMPLEMENT ACTIVITY Mar 5, 2020 Abandoned
Array ( [id] => 17578759 [patent_doc_number] => 20220135614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => SYNTHESIS OF BICYCLE TOXIN CONJUGATES, AND INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/310781 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15106 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310781 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310781
SYNTHESIS OF BICYCLE TOXIN CONJUGATES, AND INTERMEDIATES THEREOF Mar 2, 2020 Pending
Array ( [id] => 17480643 [patent_doc_number] => 20220088147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN [patent_app_type] => utility [patent_app_number] => 17/310993 [patent_app_country] => US [patent_app_date] => 2020-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17567 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310993 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/310993
LONG-ACTING GROWTH HORMONE DOSAGE FORMS WITH SUPERIOR EFFICACY TO DAILY SOMATROPIN Mar 2, 2020 Pending
Array ( [id] => 17322585 [patent_doc_number] => 11213572 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-04 [patent_title] => Cartilage regeneration composition containing HAPLN1 as active ingredient [patent_app_type] => utility [patent_app_number] => 16/805420 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 4689 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16805420 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/805420
Cartilage regeneration composition containing HAPLN1 as active ingredient Feb 27, 2020 Issued
Array ( [id] => 16598074 [patent_doc_number] => 20210024605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => CYCLIC PEPTIDE ANALOGS OF MELANOCORTIN AND AMANITIN AND METHODS OF MAKING SUCH [patent_app_type] => utility [patent_app_number] => 16/804465 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804465 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/804465
Cyclic peptide analogs of melanocortin and amanitin and methods of making such Feb 27, 2020 Issued
Array ( [id] => 16695493 [patent_doc_number] => 10946062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Use of recombinant protein for treating metabolic disorders [patent_app_type] => utility [patent_app_number] => 16/802171 [patent_app_country] => US [patent_app_date] => 2020-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2857 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16802171 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/802171
Use of recombinant protein for treating metabolic disorders Feb 25, 2020 Issued
Array ( [id] => 19423766 [patent_doc_number] => 12083157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => Use of polylysine dendrimers in the prevention and management of acne-prone skin and acneic skin [patent_app_type] => utility [patent_app_number] => 17/441482 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 12522 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441482 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/441482
Use of polylysine dendrimers in the prevention and management of acne-prone skin and acneic skin Feb 20, 2020 Issued
Array ( [id] => 16954914 [patent_doc_number] => 11058742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-07-13 [patent_title] => Food composition for suppressing hepatic lipogenesis [patent_app_type] => utility [patent_app_number] => 16/797211 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 32 [patent_no_of_words] => 7456 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797211 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/797211
Food composition for suppressing hepatic lipogenesis Feb 20, 2020 Issued
Array ( [id] => 17460257 [patent_doc_number] => 20220073562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-10 [patent_title] => PEPTIDE FOR SKIN AGING PREVENTION AND WRINKLE REDUCTION, AND COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 17/422494 [patent_app_country] => US [patent_app_date] => 2020-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422494 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422494
Peptide for skin aging prevention and wrinkle reduction, and composition comprising same Jan 21, 2020 Issued
Array ( [id] => 17480612 [patent_doc_number] => 20220088116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors [patent_app_type] => utility [patent_app_number] => 17/420396 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420396 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/420396
Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors Jan 19, 2020 Pending
Array ( [id] => 17563169 [patent_doc_number] => 20220127318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => RECOMBINANT LUBRICINS, AND COMPOSITIONS AND METHODS FOR USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/422736 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422736
RECOMBINANT LUBRICINS, AND COMPOSITIONS AND METHODS FOR USING THE SAME Jan 14, 2020 Pending
Array ( [id] => 17563174 [patent_doc_number] => 20220127323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => NOVEL POLYPEPTIDE AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/421297 [patent_app_country] => US [patent_app_date] => 2020-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20013 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421297
NOVEL POLYPEPTIDE AND THERAPEUTIC USES THEREOF Jan 6, 2020 Pending
Array ( [id] => 16908069 [patent_doc_number] => 11040086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof [patent_app_type] => utility [patent_app_number] => 16/730251 [patent_app_country] => US [patent_app_date] => 2019-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2368 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16730251 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/730251
Active peptide for enhancing the phagocytic functions of retinal pigment epithelium and a use thereof Dec 29, 2019 Issued
Array ( [id] => 17480703 [patent_doc_number] => 20220088207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 [patent_app_type] => utility [patent_app_number] => 17/416562 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10070 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416562 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/416562
BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 Dec 22, 2019 Pending
Menu